AtaiBeckley (ATAI) Free Cash Flow (2020 - 2026)
AtaiBeckley (ATAI) reported Free Cash Flow of -$23.7 million for Q3 2025, down 22.28% on a YoY basis from -$30.4 million in Q3 2024, and down 66.35% sequentially from -$14.2 million in Q2 2025.
AtaiBeckley (ATAI) Free Cash Flow (2020 - 2026) Analysis & Trends
AtaiBeckley's Free Cash Flow history runs 2 years deep, the most recent figure standing at -$21.1 million for Q1 2026.
- On a quarterly basis, Free Cash Flow fell 16.46% year-over-year to -$21.1 million in Q1 2026; TTM through Mar 2026 was -$39.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$103.6 million, down 25.63% from the prior year.
- Free Cash Flow declined to -$23.7 million in Q3 2025, from -$14.2 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$18.1 million in Q1 2025 and bottomed at -$21.1 million in Q1 2026.
- A 5-year average of -$20.6 million and a median of -$22.0 million in 2023 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow tumbled 31956.0% in 2022 and jumped 35.58% in 2023, its largest moves.
- Tracing ATAI's Free Cash Flow over 5 years: stood at -$20.4 million in 2021, then plunged by 50.16% to -$30.6 million in 2022, then rose by 28.08% to -$22.0 million in 2023, then retreated by 10.22% to -$24.3 million in 2024, then advanced by 2.63% to -$23.7 million in 2025.
- Business Quant data shows ATAI's Free Cash Flow at -$23.7 million in Q3 2025, -$14.2 million in Q2 2025, and -$18.1 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | AtaiBeckley | 2.56 Bn | 2.56 Bn | - | -23.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.09 Mn |
| Mar 31, 2026 | -21.09 Mn |
| Sep 30, 2025 | -23.66 Mn |
| Sep 30, 2025 | -23.66 Mn |
| Jun 30, 2025 | -14.22 Mn |
| Jun 30, 2025 | -14.22 Mn |
| Mar 31, 2025 | -18.11 Mn |
| Mar 31, 2025 | -18.11 Mn |
| Mar 31, 2025 | -18.11 Mn |
| Mar 31, 2025 | -18.11 Mn |
| Dec 31, 2024 | -24.30 Mn |
| Dec 31, 2024 | -24.30 Mn |
| Sep 30, 2024 | -19.35 Mn |
| Sep 30, 2024 | -19.35 Mn |
| Jun 30, 2024 | -16.23 Mn |
| Jun 30, 2024 | -16.23 Mn |
| Mar 31, 2024 | -22.57 Mn |
| Mar 31, 2024 | -22.57 Mn |
| Dec 31, 2023 | -22.04 Mn |
| Dec 31, 2023 | -22.04 Mn |